BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38791999)

  • 1. Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database.
    Eule CJ; Hu J; Hedges D; Jani A; Pshak T; Manley BJ; Sanchez A; Dreicer R; Myint ZW; Zakharia Y; Lam ET
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of Morphological Features of Clear Cell Renal Cell Carcinoma With
    Liu Y; Li Y; Xu H; Zhou L; Yang X; Wang C
    Int J Surg Pathol; 2023 Dec; 31(8):1485-1494. PubMed ID: 36911986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired Cystic Kidney Disease-associated Renal Cell Carcinoma (ACKD-RCC) Harbor Recurrent Mutations in KMT2C and TSC2 Genes.
    Shah A; Lal P; Toorens E; Palmer MB; Schwartz L; Vergara N; Guzzo T; Nayak A
    Am J Surg Pathol; 2020 Nov; 44(11):1479-1486. PubMed ID: 32604168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations in renal cell carcinomas from Chinese patients revealed by whole exome sequencing.
    Wang J; Xi Z; Xi J; Zhang H; Li J; Xia Y; Yi Y
    Cancer Cell Int; 2018; 18():159. PubMed ID: 30349421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations.
    Karlo CA; Di Paolo PL; Chaim J; Hakimi AA; Ostrovnaya I; Russo P; Hricak H; Motzer R; Hsieh JJ; Akin O
    Radiology; 2014 Feb; 270(2):464-71. PubMed ID: 24029645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic characterization of renal epithelial neoplasms arising in nonfunctioning kidneys.
    Lin X; Goyal R; Yang XJ
    Hum Pathol; 2020 Mar; 97():1-7. PubMed ID: 31857138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
    Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
    Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACKD-RCC)-like Cysts.
    Sun Y; Argani P; Tickoo SK; Epstein JI
    Am J Surg Pathol; 2018 Oct; 42(10):1396-1401. PubMed ID: 30001236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
    Khurana KK; Truong LD; Verani RR
    Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma.
    Togo Y; Yoshikawa Y; Suzuki T; Nakano Y; Kanematsu A; Zozumi M; Nojima M; Hirota S; Yamamoto S; Hashimoto-Tamaoki T
    Int J Oncol; 2016 Apr; 48(4):1571-80. PubMed ID: 26891804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene mutation profiling and clinical significances in patients with renal cell carcinoma.
    Wang Y; He P; Zhou X; Wang C; Fu J; Zhang D; Liao D; Zhou Z; Wu C; Gong W
    Clinics (Sao Paulo); 2023; 78():100259. PubMed ID: 37515929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma co-existent with other renal disease: clinico-pathological features in pre-dialysis patients and those receiving dialysis or renal transplantation.
    Peces R; Martínez-Ara J; Miguel JL; Arrieta J; Costero O; Górriz JL; Picazo ML; Fresno M
    Nephrol Dial Transplant; 2004 Nov; 19(11):2789-96. PubMed ID: 15316098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population.
    Suh J; Jeong CW; Choi S; Ku JH; Kim HH; Kim K; Kwak C
    BMC Urol; 2020 Aug; 20(1):125. PubMed ID: 32811483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Cell Carcinoma in End-Stage Renal Disease: A Retrospective Study in Patients from Hungary.
    Semjén D; Dénes B; Somorácz Á; Fintha A; Forika G; Jenei A; Dobi D; Micsik T; Eizler KV; Giba N; Sánta F; Sejben A; Iványi B; Kuthi L
    Pathobiology; 2023; 90(5):322-332. PubMed ID: 36696889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic profiles of renal cell carcinoma in a small Chinese cohort.
    Tai S; Xu DD; Yu Z; Guan Y; Yin S; Xiao J; Xue S; Liang C
    Front Oncol; 2023; 13():1095775. PubMed ID: 37427096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis.
    Rosellini M; Mollica V; Marchetti A; Coluccelli S; Giunchi F; Tassinari E; Ricci C; Fiorentino M; Tallini G; De Biase D; Massari F
    Pathol Res Pract; 2024 Feb; 254():155142. PubMed ID: 38277752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma.
    Carlo MI; Manley B; Patil S; Woo KM; Coskey DT; Redzematovic A; Arcila M; Ladanyi M; Lee W; Chen YB; Lee CH; Feldman DR; Hakimi AA; Motzer RJ; Hsieh JJ; Voss MH
    Kidney Cancer; 2017 Jul; 1(1):49-56. PubMed ID: 30334004
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma.
    Gossage L; Murtaza M; Slatter AF; Lichtenstein CP; Warren A; Haynes B; Marass F; Roberts I; Shanahan SJ; Claas A; Dunham A; May AP; Rosenfeld N; Forshew T; Eisen T
    Genes Chromosomes Cancer; 2014 Jan; 53(1):38-51. PubMed ID: 24166983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.
    Tennenbaum DM; Manley BJ; Zabor E; Becerra MF; Carlo MI; Casuscelli J; Redzematovic A; Khan N; Arcila ME; Voss MH; Feldman DR; Motzer RJ; Benfante NE; Coleman JA; Russo P; Hsieh JJ; Hakimi AA
    Urol Oncol; 2017 Aug; 35(8):532.e7-532.e13. PubMed ID: 28408295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired cystic kidney disease-associated renal cell carcinoma: a clinicopathologic study of three cases].
    Zhang W; Xu LL; Yu WJ; Wang Q; Jiang YX; Liu Y; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):366-371. PubMed ID: 29783804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.